Position in FULC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$463,202
-$886,288 QoQ
Shares Held
126,558
-28.1% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 154 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Derivatives in FULC
reported options exposure · as of Dec 31, 2024CallValue
$272,130
CallShares
57,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. FULC ranks #151 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in FULC
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $463,202 | 126,558 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,349,490 | 175,944 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $744,786 | 65,852 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $163,999 | 17,826 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $94,084 | 13,675 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $272,130 | 57,900 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $314,624 | 88,130 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $206,703 | 57,900 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $753,300 | 121,500 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $152,005 | 24,517 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $189,744 | 20,100 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $515,046 | 54,560 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $261,516 | 58,900 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $332,610 | 100,791 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $911,176 | 319,711 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $151,586 | 30,936 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $718,226 | 30,369 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $340,161 | 19,229 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $165,703 | 13,878 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||